Fig. 2From: Improvement of quality of life through glycemic control by liraglutide, a GLP-1 analog, in insulin-naive patients with type 2 diabetes mellitus: the PAGE1 studyChanges of DTR-QOL scores in each quartile of the change of HbA1c or body weight. The changes in the total DTR-QOL score and each domain score between baseline and 12 weeks after the initiation of liraglutide in each quartile of change in HbA1c and body weight are shownBack to article page